Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...

Human growth hormone is important in many aspects of growth and development. For children living with growth hormone deficiency, it can involve more than just physical growth differences. Cognitive ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...

Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved long-acting once-weekly somatrogon for children with growth hormone deficiency. Somatrogon was ...

Ngenla, a hormone drug from partners Pfizer and Opko Health, is now FDA approved for treating children with growth hormone deficiency. The once-weekly injectable biologic will compete against an ...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating ...

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing ...

Growth failure has been observed in children with the acquired immunodeficiency syndrome (AIDS), but the growth pattern in asymptomatic HIV-infection or in AIDS-related complex (ARC) is unknown. We ...

Pfizer disclosed the regulatory action late Friday. FDA complete response letters are not public documents, and the company did not say what concerns or questions were raised by the agency about the ...

In a bid to protect sales for its human growth hormone drug Genotropin, Pfizer licensed rights to a longer-lasting human growth hormone therapy, hGH-CTP, in December. This longer-lasting drug has just ...